| Literature DB >> 30568984 |
Souleymane Sawadogo1, Andreas Shiningavamwe2, Clay Roscoe1, Andrew L Baughman1, Taffa Negussie1, Gram Mutandi1, Chunfu Yang3, Ndapewa Hamunime4, Simon Agolory1.
Abstract
Three hundred sixty-six adult patients in Namibia with second-line virologic failures were evaluated for human immunodeficiency virus drug-resistant (HIVDR) mutations. Less than half (41.5%) harbored ≥1 HIVDR mutations to standardized second-line antiretroviral therapy (ART) regimen. Optimizing adherence, viral load monitoring, and genotyping are critical to prevent emergence of resistance, as well as unnecessary switching to costly third-line ART regimens.Entities:
Keywords: ART; Namibia; drug resistance; second line
Year: 2018 PMID: 30568984 PMCID: PMC5798139 DOI: 10.1093/ofid/ofy014
Source DB: PubMed Journal: Open Forum Infect Dis ISSN: 2328-8957 Impact factor: 3.835